Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-29 5:24 pm Unchanged | 2023-03-27 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,619,135 13.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 3,707,891 7.700% | 641,650 (+20.93%) | Filing History |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 5,269,287 9.900% | 3,219,287 (+157.04%) | Filing History |
| 2023-02-13 5:57 pm Purchase | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Capital VIII, LLC | 4,340,212 9.000% | 4,340,212 (New Position) | Filing History |
| 2023-02-13 06:40 am Unchanged | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Auspice Ltd | 941,206 1.960% | 0 (Unchanged) | Filing History |
| 2023-02-10 3:57 pm Unchanged | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 2,851,287 5.760% | 0 (Unchanged) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN | FMR LLC | 7,378,641 14.901% | 1,736,567 (+30.78%) | Filing History |
| 2023-02-09 06:15 am Sale | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Auspice Ltd | 941,206 1.960% | -470,000 (-33.30%) | Filing History |
| 2023-02-08 5:24 pm Unchanged | 2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN | BML Investment Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:23 pm Sale | 2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN | BML Investment Partners, L.P. | 0 0.000% | -1,764,274 (Position Closed) | Filing History |
| 2023-02-06 2:45 pm Sale | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,901,566 6.100% | -63,304 (-2.14%) | Filing History |
| 2023-01-03 4:58 pm Purchase | 2022-12-21 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT LLC | 3,448,275 7.000% | 3,448,275 (New Position) | Filing History |
| 2022-12-29 2:57 pm Sale | 2022-12-27 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,964,870 6.180% | -1,816,696 (-37.99%) | Filing History |
| 2022-12-28 5:14 pm Purchase | 2022-12-23 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,619,135 15.400% | 137,931 (+1.84%) | Filing History |
| 2022-12-23 3:35 pm Purchase | 2022-12-23 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 2,851,287 5.940% | 991,287 (+53.30%) | Filing History |
| 2022-12-12 08:41 am Purchase | 2022-12-09 | 13G | Terns Pharmaceuticals, Inc. TERN | FMR LLC | 5,642,074 14.999% | 5,539,780 (+5415.55%) | Filing History |
| 2022-08-26 7:24 pm Purchase | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 3,066,241 8.200% | 3,066,241 (New Position) | Filing History |
| 2022-08-25 09:32 am Purchase | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 2,050,000 5.450% | 2,050,000 (New Position) | Filing History |
| 2022-08-18 4:39 pm Purchase | 2022-08-16 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,481,204 19.900% | 3,690,000 (+97.33%) | Filing History |
| 2022-08-16 5:20 pm Sale | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Deerfield Mgmt, L.P. | 1,860,000 4.940% | -485,959 (-20.71%) | Filing History |